A detailed history of Tcg Advisory Services, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Tcg Advisory Services, LLC holds 8,210 shares of TGTX stock, worth $254,510. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,210
Previous 11,013 25.45%
Holding current value
$254,510
Previous $396,000 25.25%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$26.39 - $39.19 $73,971 - $109,849
-2,803 Reduced 25.45%
8,210 $296,000
Q2 2025

Aug 14, 2025

BUY
$33.37 - $45.51 $116,027 - $158,238
3,477 Added 46.14%
11,013 $396,000
Q1 2025

May 15, 2025

SELL
$27.67 - $42.99 $31,128 - $48,363
-1,125 Reduced 12.99%
7,536 $297,000
Q4 2024

Feb 11, 2025

SELL
$21.31 - $35.09 $7,522 - $12,386
-353 Reduced 3.92%
8,661 $260,000
Q3 2024

Nov 14, 2024

BUY
$17.21 - $25.28 $155,130 - $227,873
9,014 New
9,014 $210,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.5B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Tcg Advisory Services, LLC Portfolio

Follow Tcg Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Advisory Services, LLC with notifications on news.